Wellness Wednesday: FDA Approves Postpartum Depression Drug
A drug made to help treat postpartum depression is now available for the first time in U.S. history.
The Food and Drug Administration last month approved the drug specifically intended to treat symptoms of postpartum depression, a mental illness that affects nearly one-tenth of new mothers after childbirth.
Today on All Sides Wellness Wednesday, the first postpartum depression drug and more.
- Dr. Dana Stern, dermatologist, nail specialist, assistant clinical professor of Dermatology at the Mount Sinai Medical Center in New York City
- Tonya Fulwider, Associate Director at Mental Health America of Franklin County, Co-founder of Perinatal Outreach and Encouragement for Moms
- Dr. Jaqueline Worth, New York City-based OB-GYN
- Denise Grady, science reporter, The New York Times